david andrews: Clinical Trials

1 trial sponsored by david andrews, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1

Follow david andrews: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma
IGF-1R/AS ODN; Surgery with tissue harvest and implantation 20 diffusion chambers in the rectus sheath with IGF-1R/AS ODN within 24 hours of craniotomy, implanted for 48 hours. - Malignant Glioma, Neoplasms
Phase 1Completeddavid andrews332015-09-012025-05-07

Conditions studied

Brain Neoplasms (1)  ·  Glioma (1)  ·  Neoplasms (1)

Interventions

Craniotomy (1)  ·  Drug Implants (1)  ·  Surgical Procedures, Operative (1)  ·  Tissue and Organ Harvesting (1)

Countries

United States (1)

Top investigators

Kevin Judy, MD (1)

Results publications

PMID 33500356